title: Intracoronary infusion of Gd3+ into ischemic region does not suppress phase Ib ventricular arrhythmias after coronary occlusion in swine.
abstract: Increased mechanical tension in the ischemic region during acute coronary occlusion might favor the occurrence of phase Ib ventricular arrhythmias. We aimed to investigate whether intracoronary administration of Gd(3+), a stretch-activated channel blocker, into the ischemic zone reduces the incidence of these arrhythmias. In thiopental-anesthetized, open-chest pigs, the left anterior descending coronary artery (LAD) was ligated for 45 or 48 min. Phosphate-free, HEPES-buffered saline bubbled with 100% N(2) was infused into the ischemic region for 4 min, starting 5 min (series A; n = 16) or 20 min (series B; n = 16) after coronary occlusion, at a rate doubling the baseline blood flow. Animals were blindly allocated to receive 40 muM Gd(3+) or only the buffer during the final 2 min of the infusion. There were no differences between groups with respect to hemodynamic variables, plasma K(+) levels, or size of the ischemic region. In neither series was the number of phase Ib premature ventricular beats reduced by Gd(3+) (46 +/- 20 in untreated vs. 91 +/- 37 in Gd(3+)-treated animals in series A and 19 +/- 7 vs. 22 +/- 13, respectively, in series B; both P = not significant). The occurrence of ventricular tachycardia or fibrillation was significantly associated with the magnitude of early ischemic expansion of the LAD region, as measured by ultrasonic crystals, but was also not prevented by Gd(3+). These results argue against a major role of stretch-activated channels inside the area at risk in the genesis of phase Ib ischemic ventricular arrhythmias.
authors.affiliation: Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Pg. Vall d'Hebron 119-129, E-08035 Barcelona, Spain.
authors.forename: José A
authors.initials: JA
authors.lastname: Barrabés
authors.forename: David
authors.initials: D
authors.lastname: Garcia-Dorado
authors.forename: Luis
authors.initials: L
authors.lastname: Agulló
authors.forename: Antonio
authors.initials: A
authors.lastname: Rodríguez-Sinovas
authors.forename: Ferran
authors.initials: F
authors.lastname: Padilla
authors.forename: Lourdes
authors.initials: L
authors.lastname: Trobo
authors.forename: Jordi
authors.initials: J
authors.lastname: Soler-Soler
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000503:physiopathology*; D001784:Blood Gas Analysis; D003331:Coronary Vessels / Q000502:physiology; D004562:Electrocardiography; D005260:Female; D005682:Gadolinium / Q000008:administration & dosage / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D007267:Injections; D008297:Male; D009119:Muscle Contraction / Q000502:physiology; D017202:Myocardial Ischemia / Q000503:physiopathology*; D013318:Stroke Volume / Q000502:physiology; D013552:Swine; D013610:Tachycardia / Q000503:physiopathology; D018879:Ventricular Premature Complexes / Q000503:physiopathology
chemical_list: D000889:Anti-Arrhythmia Agents; D005682:Gadolinium